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Diagnostic imaging of cervical intraepithelial
neoplasia based on hematoxylin and eosin
fluorescence
Mario R. Castellanos1*, Anita Szerszen5, Stephen Gundry2, Edyta C. Pirog3, Mitchell Maiman4, Sritha Rajupet1,
John Paul Gomez1, Adi Davidov4, Priya Ranjan Debata6, Probal Banerjee6 and Jimmie E. Fata7*
Abstract
Background: Pathological classification of cervical intraepithelial neoplasia (CIN) is problematic as it relies on
subjective criteria. We developed an imaging method that uses spectroscopy to assess the fluorescent intensity of
cervical biopsies derived directly from hematoxylin and eosin (H&E) stained tissues.
Methods: Archived H&E slides were identified containing normal cervical tissue, CIN I, and CIN III cases, from a
Community Hospital and an Academic Medical Center. Cases were obtained by consensus review of at least 2
senior pathologists. Images from H&E slides were captured first with bright field illumination and then with
fluorescent illumination. We used a Zeiss Axio Observer Z1 microscope and an AxioVision 4.6.3-AP1 camera at
excitation wavelength of 450–490 nm with emission captured at 515–565 nm. The 32-bit grayscale fluorescence
images were used for image analysis.
Results: We reviewed 108 slides: 46 normal, 33 CIN I and 29 CIN III. Fluorescent intensity increased progressively in
normal epithelial tissue as cells matured and advanced from the basal to superficial regions of the epithelium. In
CIN I cases this change was less prominent as compared to normal. In high grade CIN lesions, there was a slight or
no increase in fluorescent intensity. All groups examined were statistically different.
Conclusion: Presently, there are no markers to help in classification of CIN I-III lesions. Our imaging method may
complement standard H&E pathological review and provide objective criteria to support the CIN diagnosis.
Keywords: Diagnostic imaging, Cervical neoplasia, Hematoxylin and eosin, Fluorescence imaging
Background
Cervical cancer is the second most common malignancy
among women worldwide, with 80 % of cases occurring
in low-income countries [1, 2]. In the United States, cer-
vical cancer screening programs are effective in prevent-
ing cancer and reducing related mortality [3]. However,
there are significant areas that need improvement such
as the correct histopathological grade classification of
cervical intraepithelial neoplasia (CIN) using light mi-
croscopy [4, 5]. Most CIN grade I (CIN I) lesions are
transient viral infections and as per guidelines require
surveillance [3, 6, 7]. Lesions diagnosed as CIN II and
above usually necessitate treatment, especially in women
30 years of age and older [3, 8, 9]. The threshold to treat
a patient is based on histopathological classification of
CIN, yet criteria for grading are subjective and have high
inter- and intra-observer variability [3, 8, 9]. The CIN
diagnosis is based on the assessment of the immature
parabasal cell expansion within the epithelial thickness.
In CIN I, the parabasal cells are confined to the lower 1/3
of the epithelium. In CIN II lesions, the immature cells
are located between 1/3 and 2/3 of the epithelial thickness,
and in CIN III the abnormal growth expands to the upper
1/3. Using these criteria, the identification and grading of
CIN is difficult [10, 11]. Poor accuracy arises from the fact
that CIN diagnosis relies on using standard light micros-
copy to subjectively identify the localization of mitosis,
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and the extent of the upward growth of abnormal cells
[3, 10]. Yet, non-cancerous epithelial changes: cervical
atrophy, squamous metaplasia and cellular atypia associ-
ated with inflammation, may appear like CIN and make
the diagnosis even more difficult [3]. In a large multicen-
tered study that used expert pathologists to re-examine
over 1000 cervical biopsies [12], the inter-observer agree-
ment was low with a κ of 0.54 (95 % CI, 0.50-0.58). The
greatest number of diagnostic disagreements in this study
was between normal cervical tissue and CIN I, in which
only 30 % of negative cases were agreed upon by study
experts.
Incorrect classification of cervical lesions has a major
impact on patient care. Patients may either be over-
treated or risk having a high grade dysplasia missed. Fur-
thermore, there are economic issues associated with an
inaccurate diagnosis of CIN. In the U.S., the annual
healthcare cost to screen and treat HPV-related cervical
disease is about $6.5 billion [13]. Inaccurate classifica-
tion of a patient’s risk to develop cervical cancer impacts
post-colposcopy and biopsy surveillance protocols,
which radically affects cost. Therefore, there is an urgent
need to develop unique methods to improve the histo-
pathological diagnosis and grading of CIN.
Fluorescence spectroscopy is a promising diagnostic
technique to examine the inherent auto-fluorescence of
tissue and its spectral characteristics, which allow the
discrimination of normal tissue from pre-cancerous or
cancerous lesions [14]. Endogenous fluorophores such as
cytokeratins, NADP, aromatic amino acids, lipo-
pigments, and various proteins, such as collagen and
elastin, all fluoresce upon light excitation [14–18]. Cell
and tissue auto-fluorescence provides valuable informa-
tion about the microenvironment during physiological
and/or pathological states and can identify intracellular
alterations in metabolism [17]. For instance, cellular
transformation alters the light emission of mitochondrial
fluorophores and, therefore, changes in epithelial-
stromal interactions can be detected by the evident de-
crease in stromal collagen fluorescence as normal tissue
progresses to a pre-cancerous lesion [17].
Detection of cervical lesions in vivo has been facili-
tated by the use of optical imaging [19–24]. In 2006, the
Food and Drug Administration (FDA) approved the first
in vivo optical imaging device for diagnosis of high grade
cervical dysplasia (CIN II and III) during colposcopy
[21]. Tissue auto-fluorescence and reflectance properties
can mark abnormal areas. Similarly, ex vivo examination
of cervical biopsies using fluorescence spectroscopy can
be done but has not been sufficiently evaluated despite
promising data [25].
The goal of our study was to examine the fluorescence
spectrum of generally used hematoxylin and eosin
(H&E) stained cervical tissue, to assess its diagnostic
potential. Eosin is a fluorescent red dye, which is a bro-
minated derivative of fluorescein. Protein–eosin com-
plexes increase proportionally to the concentration of
the protein present [26–29]. Given these properties of
eosin, we set out to determine whether a unique fluores-
cent signature can be derived from H&E-stained tissue,
such that normal tissue can be distinguished from
abnormal, and that CIN I can be differentiated from
CIN III. Our findings suggest that fluorescence imaging
of H&E stained cervical tissue is a new method that may




Colposcopy Clinic medical records were reviewed from
two medical centers, Staten Island University Hospital
(SIUH) and Weill Cornell Medical College, to find
women that had undergone a biopsy for an abnormal
PAP smear. A total of 111 slides were obtained diag-
nosed as Normal, CIN I, or CIN III. In this study in
which fluorescence imaging was being evaluated to
examine lesions likely to progress and compare them to
lesions likely to regress, CIN II cases were not selected
for review. This was done because CIN II cases are a
heterogeneous group of lesions that either behave like
CIN I or CIN III study [28], therefore for this explora-
tory study the focus was to evaluate cases in which bio-
logic behavior is better defined. Cases of CIN I and CIN
III were classified according the original criteria devel-
oped by R. Richart [28]. Nuclear atypia was considered
to be diagnostic for dysplasia and the grading system
was based on the expansion of the immature dysplastic
basal cells within the epithelial thickness. Cases with
expansion confined to the lower 1/3 of the epithelial
thickness were classified as CIN I and cases with expan-
sion to the upper 1/3 epithelial thickness were classified
as CIN III.
SIUH-archived H&E-stained slides were re-examined
to select biopsies that had classic histopathologic charac-
teristics for each category [3]. Any equivocal specimens
were excluded. Cases were obtained by consensus of at
least 2 pathologists. Only cases that had HPV DNA test-
ing with Hybrid Capture II (HC2, Qiagen, Baltimore,
USA) for both high and low risk HPV were considered,
to improve the correct classification of CIN 1 lesions.
The Normal group consisted of biopsies that had normal
histology, in addition to a normal PAP smear and a
negative HPV HCII test. Cases of squamous metaplasia,
severe chronic cervicitis and/ or atrophy were excluded.
For Weill Cornell Medical College specimens, the histo-
logic diagnosis of CIN I or CIN III was confirmed by
positive KI-67 immunostaining and HPV DNA by SPF10
PCR-LiPA25. Cases of normal cervical tissue were
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obtained from hysterectomies for leiomyomata. HPV
negativity was confirmed with negative HC II test.
This work was performed under the IRB protocol #:
SIUH08-043, which was reviewed and approved by the
North Shore LIJ Staten Island University Hospital IRB
(FWA #00002417; 500 Seaview Avenue, Staten Island
NY 10305). The study was exempted from the HIPAA
requirement for authorization and granted a waiver of
consent as the pathological specimens used were fully
de-identified.
H&E staining
Cervical tissue specimens: The formalin-fixed cervical
tissue specimens were collected from the repository of
each institution; the samples were serially cut, and the
sections (about 4 microns in size) were stained with
Hematoxylin and Eosin (H&E) by standard procedure
using an automated H&E staining machine.
Image capture
Images of the H&E stained cervical tissue sections were
acquired using a Zeiss Axio Observer Z1 microscope
and an AxioVision 4.6.3-AP1 camera using brightfield
and at an excitation wavelength of 450–490 nm with
emission captured at 515–565 nm (Fig. 1). The 32-bit
grayscale fluorescent images were used for image ana-
lysis (see below). The same exposure time was used
across all samples.
Image analysis
32-bit grayscale fluorescent images were opened on Ima-
geJ for image processing and analysis. ImageJ is a publi-
cally accessible image processing program developed at
the National Institutes of Health. Firstly, multiple
straight vertical parallel lines, originating from the epi-
thelial basement membrane to the uppermost part of the
surface epithelium, were drawn (Fig. 2a). The length of
each line varied depending on the epithelium thickness
Fig. 1 Fluorescent representation of normal, CIN I and CIN III cervical tissue specimens. a, d and g represent H&E stained cervical
tissue. b, e and h represent inherent fluorescence of H&E sections at an excitation wavelength of 488 nm. c, f and i represent a color-map image
in which fluorescent intensity is represented as shades (blue > green > yellow > red; high to low intensity). a, b, c = normal cervical tissue. d, e, f =
CIN I cervical tissue. g, h, i = CIN III cervical tissue. Notice the lack of intensity in epithelium as you move from normal (c) to CIN I (f) to CIN III (i)
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Fig. 2 Quantifying average fluorescent values for normal, CIN I and CIN III cervical tissue. a Cervical epithelium divided into equidistant segments:
segment 1 (bottom third), segment 2 (middle), and segment 3 (upper third). b Plotted fluorescent intensity profile of a line drawn from segment 1 to
segment 3 on a normal sample. Segments are derived empirically by dividing the line distance into three parts. c Average fluorescent intensity for
each segment derived from Normal, CIN I, and CIN III. Normal tissue is significantly higher in fluorescence intensity in all three segments when
compared to CIN I and CIN III (p < 0.05). No significant differences were evident between CIN I and CIN III. Results are generated by averaging greater
than 20 segmented lines for each sample. Total samples in each histological category are Normal = 13, CIN I = 18, CIN III = 12
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(from basement membrane to surface epithelium). After
each line was drawn, the ImageJ Plot Profile command
was applied and the raw data were listed, copied and
placed on a spreadsheet for post-analysis.
ImajeJ demonstrated the fluorescent intensity, using
Gray Value, as it corresponds to the drawn line (Fig. 2a).
Similar to how the epithelium is divided into areas using
the CIN nomenclature (lower 1/3, middle 1/3, upper 1/3);
the data from each drawn line was separated into 3
equidistant segments (Fig. 2a). For example, a line cov-
ering the full thickness of the epithelium having a length
of 600 pixels would be divided into 0–200 (lower 1/3
segment), 201–400 (middle 1/3 segment), and 401–600
(upper 1/3 segment) (Fig. 2a). The data points from the
drawn line as they correspond to the fluorescent inten-
sity in each segment were plotted so that the X-axis rep-
resents the distance between the points on the drawn
line measured by pixels and the Y-axis represents fluor-
escent intensity (Fig. 2b). The fluorescent intensity
values were first analyzed without filtering any data
points (Fig. 2b). Then, analysis was done by filtering
lower values. The filtering removed variations caused by
non-fluorescent black areas within the epithelial cells
such as cytoplasmic glycogen (Fig. 2b). Due to cyclic es-
trogen effects, a threshold was derived in order to elim-
inate such cyclic variations (Fig. 2b).
The average fluorescence change throughout the whole
epithelium was generated by obtaining the average fluor-
escence change in the lower, middle and upper segments.
Three data points (one point representing each segment)
were produced and used to plot a line that represents the
overall average fluorescence change (Fig. 2c). It was found
that the more fluorescent intensity exhibited by a tissue
sample, the more the slope of the plotted line. Therefore,
a tissue section that displayed increasing epithelial fluores-
cent intensities from basal to surface would have a higher
slope (Fig. 2c higher line normal case) than a tissue sample
that displayed no or minimal change in fluorescent inten-
sity in that particular area (Fig. 2c middle and lower lines
from CIN 1 & 3 cases). The slope of every line was nor-
malized to remove sources that could cause sample vari-
ation, such as those caused by differences in H&E staining
intensity or tissue thickness, images captured with differ-
ent exposure times, and varying excitation energies.
Normalization involved setting the average fluorescent in-
tensity of the basal segment to a value of 1 such that all
slopes originated from this value (Fig. 2c). This method
provided an internal control for all tissue samples and
eliminated potential sources of error.
Statistical analysis
We analyzed data from each institution separately and
jointly. To determine differences in fluorescent intensity
between Normal, CIN I and CIN III, a One-Way
ANOVA was performed followed by Tukey's Multiple
Comparison Test. Student t-Tests were performed when
comparing normalized slopes derived from the same
histological type between each institution.
Results
One hundred and eleven (111) formalin-fixed, paraffin-
embedded, and H&E-stained cervical tissue specimens
were used in this study; 47 Normal, 34 CIN I, and 30
CIN III cases (43 cases from SIUH, 68 cases from Weill
Cornell Medical College).
Images of H&E-stained cervical biopsy specimens cap-
tured first with bright field illumination (Fig. 1a, d, g),
then with fluorescent illumination (Fig. 1b, e, h) show
distinct patterns of fluorescence. Pseudo-coloring of
fluorescent images was achieved with Image J using the
Spectrum Look-Up Table (Fig. 1c, f, i). Images were gen-
erated so that different fluorescent intensities were rep-
resented by colors. Using this color map, shades of blue
correspond to the highest intensities and then decrease
in order as follows: green, yellow, and red being the
lowest.
Pseudo-coloring of fluorescent images revealed consid-
erable differences in the amount of epithelial fluores-
cence between Normal, CIN I, and CIN III (compare
Fig. 1c with f and i). Normal tissue retained a signifi-
cantly greater amount of epithelial fluorescence com-
pared to the pathological tissues (CIN I and CIN III).
The greatest intensity occurred in the cytoplasm of kerati-
nocytes found in the superficial regions of the epithelium
of normal cervix. Basal cells had the lowest intensity, while
the fluorescence intensity increased progressively as kera-
tinocytes matured and differentiated within the epithe-
lium. CIN I exhibited higher epithelial fluorescence
compared to CIN III (Fig. 1 compare f with i), but lacked
the high intensity pattern seen in the superficial region of
normal tissue. In CIN III, there was no significant increase
in epithelial fluorescence, as the cytoplasmic fluorescence
of all cells, from basal to superficial regions, was strongly
diminished. To objectively quantify the epithelial fluores-
cent intensity seen on H&E tissue samples from SIUH,
multiple straight lines (>20) were drawn from the lower
segment to the upper segment using ImageJ line draw
(Fig. 2a; normal tissue example). The ImageJ Plot Profile
command was then applied to each line to obtain a fluor-
escent intensity profile (Fig. 2b); this data was stored for
post analysis review. In the normal tissue samples pro-
vided, the fluorescent intensity plot was obtained from
drawing multiple lines across the epithelium, as shown in
Fig. 2a. The fluorescent intensity revealed a gradual in-
crease in epithelial fluorescent intensity from segment 1
(lower) to segment 3 (upper). When reviewing the H&E
slide and comparing it to the fluorescent image in Fig. 3a,
epithelial cells in the latter had bright and dark areas. The
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Fig. 3 (See legend on next page.)
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dark areas primarily correspond to areas that are devoid
of fluorescence, such as the nuclear region or cytoplasm
containing glycogen. Many factors can affect the glycogen
content of the cervical epithelium, such as menstrual
cycle, therefore, to eliminate variation due to cyclical es-
trogen; a threshold was used to obtain the highest fluores-
cent values for each segment (lower, middle and upper;
Fig. 3b). The analysis of fluorescence intensity for a par-
ticular line was done and compared in 2 % step-wise in-
crements from the bottom up. When linear regression
was applied to the plotted average fluorescent intensity
line data across each segment, unique “signatures” for
each histological type began to appear for the top 10 %
and thus a threshold was derived to be at the 89th percent-
ile. By analyzing data in this manner, normal samples had
a slope of 3110 ± 529 (fluorescent intensity value ± SEM),
CIN I had a slope of 1144 ± 151, and CIN III had a slope
of 145 ± 163. Statistical analysis (ANOVA followed by
Turkeys’ pair-wise comparisons) on the slopes of each lin-
ear regression line revealed each was significantly different
than the other (Fig. 3c; p < 0.05).
Normalization of slope data was developed to over-
come the variation likely derived from a number of
sources, such as the differences in H&E staining inten-
sity, exposure time during image capture, fluorescent
light sources, and thickness of tissue sample. Nor-
malization involved setting all basal segment data points
to 1 and adjusting all others on the same line relative to
that change. This method provided an internal control
for all tissue samples. This method therefore sets all
slopes starting at 1 (normalize fluorescent intensity) re-
gardless of potential sources of error (Fig. 4a, b). After
normalization of slopes, significant differences between
each histological type still remained (p < 0.05). Normal
tissue had the highest normalized slope value (0.37 ±
0.06), followed by CIN I (0.19 ± 0.03), and then CIN III
(0.02 ± 0.02). Pseudo-colored images from each histo-
logical type representing close approximation to these
slopes are presented (Fig. 4c).
Similar methods and results were obtained from Weill
Cornell Medical College. In these samples, normal tissue
had the highest slope (.41 ± .05), followed by CIN I (.22
± .07), with CIN III (.10 ± .02) having the lowest slope.
At the 89th percentile threshold, no significant differ-
ences existed between samples analyzed from SIUH and
Weill Cornell (Fig. 5a). More importantly, when all of
the slides were combined between the two institutions
(N = 47, CIN I = 34, and CIN III = 30), significant
differences were evident between all histological classifi-
cations (Fig. 5b).
Discussion
Fluorescence characteristics of H&E stained tissue speci-
mens were described over 30 years ago [28]. Since then,
only few investigators have used fluorescence spectros-
copy to examine H&E-stained slides for the purpose of
evaluating the tissue microenvironment. These studies
have assessed the skin, pancreas, heart, spleen, colon,
and kidney [27, 30, 28, 31–33]. They confirm the utility
and reproducibility of fluorescence spectroscopy to
characterize structures that are either difficult to
visualize or not seen using standard light microcopy, yet
become prominent with fluorescence imaging. Dinish et
al. [34] examined H&E-stained pathology slides using
fluorescence lifetime imaging microscopy and reported
that tumor-associated molecules were retained in tissues
despite fixation and staining. Fluorescence lifetime im-
aging properties were correlated with histological
changes in tissue sections. Though fluorescence spec-
troscopy appears to be a promising method to evaluate
the microenvironment of tissues, overall little work has
been done in this area and no studies have examined if
this method can aid in the diagnosis of pre-cancerous le-
sions of the cervix. Our findings indicate that unique
fluorescent signatures exist between Normal, CIN I, and
CIN III H&E-stained slides.
Our analysis and algorithm was first developed on cer-
vical tissue specimens from Staten Island University
Hospital (derivation set) and applied to a separate set of
cervical specimens obtained from Weill Cornell Medical
College (test set). The almost identical pattern between
the derivation set and test set validates these unique
fluorescent signatures (Fig. 5b). Our ability to normalize
each slide with an internal control (segment 1) allowed
us to remove any variations associated with slide prepar-
ation and staining, making possible comparisons among
institutions. Essential to our study; was the use of well
examined pathology cases determined to be ‘standards’,
representing the categories of Normal, CIN I and CIN
III cases. To overcome the difficulty in CIN diagnosis,
we used specimens from two medical centers that ob-
tained cases with two different approaches. The SIUH
data set was obtained by consensus pathologic review in
which selected cases had classic features for each histo-
logical category. This data set was previously reported
and used for the evaluation of a marker of HPV-induced
(See figure on previous page.)
Fig. 3 Linear regression analysis of segmental fluorescence intensity. a Cervical epithelium divided into equidistant segments: segment 1 (bottom
third), segment 2 (middle), and segment 3 (upper third). b Fluorescence intensity profile of the line plotted in (a). Bisecting lines represent the
89th percentile of each segment. c The highest fluorescence intensity values (top 10 %) of each segment from (b) are averaged, plotted in
(c) and analyzed with linear regression. Total samples in each histological category are Normal = 13, CIN I = 18, CIN III = 12
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Fig. 4 Normalizing linear regression to lower segment. a and b Fluorescent intensity averages in lower segments are set to 1 and all other data
points are normalized to this value. Statistical analysis of the linear regression performed on normalized slopes indicates all histological types
(N, CIN I, CIN III) are significantly different from each other (p < 0.05). Total samples in each histological category are Normal = 13, CIN I = 18, CIN
III = 12. c Pseudo-colored intensity of fluorescent images from normal, CIN I, and CIN III epithelium that closely represent the average fluorescent
intensity signature for each histological type
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transformation [35]. In addition, the selected SIUH Nor-
mal cases had a negative HPV DNA test (Hybrid Cap-
ture II) for high and low risk viruses at the time of
biopsy. The second set of slides, from the Cornell Med-
ical College, was selected and reviewed by a gynecologic
pathologist. The CIN diagnosis was confirmed by posi-
tive KI-67 immunostaining and PCR for HPV DNA.
Both data sets represented a very different population of
patients, yet the fluorescent signatures among histo-
logical categories were very similar when the threshold
of 89th percentile was used. The separation of the squa-
mous epithelium into 3 segments was important for
identifying a fluorescence pattern specific for each path-
ology group. It allowed us to evaluate the change in
fluorescence. Normal tissue retained the greatest amount
of epithelial fluorescence compared to the pathological
tissues (CIN I and CIN III). In Normal group the basal
and parabasal cells had low cytoplasmic fluorescence.
However, fluorescence in the more mature and differen-
tiated keratinocytes in the upper segments increased in
intensity, probably due to the accumulation of various
keratins and proteins associated with maturing keratino-
cytes [36]. Cells in superficial areas of normal epithelium
(segment 3, Fig. 4b, c) acquired the highest amount of
fluorescence intensity. This pattern was consistently vi-
sualized among all normal cases. This change in epithe-
lial fluorescence was objectively quantified with the
derivation of the slope data. In CIN III, a change in
fluorescence intensity within the epithelium did not
occur, as almost all of the upward expanding immature
cells, from basal to superficial areas, had no or little en-
hancement of intensity. Therefore, CIN III cases had the
lowest slope values (Fig. 4b, c). CIN I lesions demon-
strated a pattern in which there was some increase in
epithelial fluorescence but did not reach the intensity of
normal cases (Fig. 4b, c). The high fluorescence of nor-
mal epithelial tissue is known to be in part due to kera-
tin expression [15]. The lack of enhanced fluorescence
within the epithelium of CIN III lesions is most likely at-
tributed to the changes in the type of keratin expression
associated with transformation of the cervical epithelium
[37, 38]. Similarly, in CIN I the differential expression of
HPV proteins among the different layers of the epithe-
lium affects the maturation of keratinocytes [39] which
may alter the pattern of fluorescence.
It is well known that in some situations normal cases
are difficult to distinguish from CIN I, or III [4, 10]. The
University of Virginia Health System conducted a study
in which 1455 cervical biopsies were re-examined by ex-
pert consensus review and diagnoses compared to those
by community pathologists. There was 86.5 % agreement
on normal cases between experts and community pa-
thologists, 61.9 % on CIN I lesions, and 75 % on CIN III.
Biomarkers, p16(INK4a), and Ki-67, were also evaluated to
determine whether they could aide CIN diagnosis in
community hospitals. Similar to other studies, p16(INK4a)
improved diagnosis of high grade CIN, but could not be
used to distinguish CIN I from CIN III. Ki-67 also
helped diagnosis of high grade CIN but less than
p16(INK4a) and the combination of Ki-67 and p16(INK4a)
was not better in this study than p16(INK4a) alone [40].
Therefore, none of the markers currently available in the
clinical setting can distinguish the critical cutoff of CIN
I from CIN III. Yet, accurate histological grading of CIN
is vital. In our study we found that with a 89th percentile
threshold, each histological category could be
Fig. 5 Validation of unique signatures. a An analysis of normal, CIN I
and CIN III samples (N = 34, CIN III = 16, CIN III = 18) collected from a
different institution (Weill Cornell Medical College) indicated that at
a threshold of 10 % the slopes for normal and CIN I samples are not
significantly different from the samples analyzed from SIUH. b When
all samples from both institutions are combined, slopes from each
histological type are significantly different from each other
indicating a unique signature for normal, CIN I, and CIN III
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distinguished from another indicating a unique “signa-
ture” for Normal, CIN I, and CIN III. An appropriate
diagnosis of CIN has significant impact on treatment
and can affect clinical outcomes.
Seventy percent of CIN I lesions regress within one
year [3], and are transient HPV infections, thus they re-
quire no intervention. In contrast, patients diagnosed
with CIN III are likely to progress to cancer, therefore
many of these patients are treated with loop electrosur-
gical excision procedure (LEEP), especially if they are
30 years or older [3]. In our study we were able to cor-
rectly classify normal, CIN I, and CIN III.
In the study from University of Virginia Health System
[40], CIN II lesions had the lowest agreement, with only
47.6 % concordance between study and community pa-
thologists. In this current exploratory study using fluor-
escence spectroscopy we wanted to examine lesions that
are likely to progress from those that will regress, there-
fore we did not examine CIN II cases. This was done
intentionally as experts believe CIN II behavior cannot
be predicted by histology [28]. Now, that we have identi-
fied a unique fluorescent signature for CIN I and CIN
III, our research is extended to focus on CIN II lesions.
We are collecting cohorts of patients that were diag-
nosed with CIN II but were not treated in order to see if
fluorescence imaging can predict outcomes.
Our present method has several advantages, the first of
which is the ability to identify relevant areas of H&E-
stained tissue sections that pathologists examine using con-
ventional light microscopy. Fluorescence images are ob-
tained from a standard H&E-stained slide without any
other processing of the tissue and can be adopted by hos-
pital laboratories without requiring extra-technical services.
Inherent variations from the H&E staining are removed
through our normalization process. Thus staining done at
various times or at different institutions can still be com-
pared and evaluated. Another advantage of fluorescence
imaging using our method is that it overcomes the diffi-
cultly correlating abnormalities seen on H&E-stained tissue
sections with subsequent special stained slides, where serial
cut sections are required for staining. The original H&E
and special stain slides represent the same region but not
the same cells. Our method can directly image relevant
areas on H&E slide to correlate fluorescence data with
histopathology on light microscopy.
Fluorescent imaging of H&E slides may be a novel ap-
proach to evaluate cervical biopsies. In this test of con-
cept study we examined an ideal data set, as each case
represented classic lesion for each histology grade. The
development of this method requires further systematic
studies to determine its utility in resolving the current
difficulties of CIN diagnosis. We are in the process of
deriving standard fluorescent “signatures” for all CIN
categories including mimics of CIN, like cervical
atrophy, squamous metaplasia and cellular atypia associ-
ated with inflammation. Future studies will need to es-
tablish fluorescent signatures for these diagnoses as well.
Conclusions
In conclusion, our diagnostic method uses standard
H&E-stained tissue slides and provides quantitative in-
formation that could make the diagnosis of cervical dys-
plasia more accurate. We presented steps towards
enabling quantitative pathology through the use of a
normalized image-processing algorithm. The algorithm
takes into account the concentration of eosin (via fluor-
escence imaging) as a function of spatial position (across
the epithelium) and provides clinicians with a quantita-
tive metric system that correlates with a diagnostic
grade.
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